ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "83fcaaec-9fe7-4416-b692-80a375b688bd"}, "_deposit": {"id": "20235", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "20235"}, "status": "published"}, "_oai": {"id": "oai:soar-ir.repo.nii.ac.jp:00020235", "sets": ["462"]}, "author_link": ["106729", "106730", "106731", "106732", "106733", "106734", "106735", "106736", "106737", "106738", "106739", "106740"], "item_1628147817048": {"attribute_name": "出版タイプ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_ab4af688f83e57aa", "subitem_version_type": "AM"}]}, "item_6_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2016-11-17", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "6", "bibliographicPageEnd": "905", "bibliographicPageStart": "897", "bibliographicVolumeNumber": "37", "bibliographic_titles": [{"bibliographic_title": "LIVER INTERNATIONAL"}]}]}, "item_6_description_20": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Background \u0026 Aims\u003cbr/\u003ePrimary biliary cholangitis (PBC) is an autoimmune liver disease characterized by portal inflammation and immune‐mediated destruction of intrahepatic bile ducts that often leads to liver decompensation and liver failure. Although the biochemical response to ursodeoxycholic acid (UDCA) can predict disease outcome in PBC, few biomarkers have been identified as prognostic tools applicable prior to UDCA treatment. We therefore sought to identify such indicators of long‐term outcome in PBC in the Japanese population.\u003cbr/\u003eMethods\u003cbr/\u003eThe prebiopsy serum samples and subsequent clinical data of 136 patients with PBC treated with UDCA were analysed over a median follow‐up period of 8.8 years. Serum levels of biomarkers related to microbial translocation (sCD14, EndoCAb and I‐FABP) were measured along with those of 33 cytokines and chemokines and additional auto‐antibodies. Associations between the tested parameters and the clinical outcomes of liver decompensation and liver‐related death/liver transplantation were evaluated using the Cox proportional hazards model with stepwise methods and Kaplan‐Meier analysis.\u003cbr/\u003eResults\u003cbr/\u003eElevated levels of serum IL‐8, and sCD14 before UDCA therapy were significantly associated with both liver decompensation and liver‐related death/liver transplantation. In multivariate analyses, IL‐8≥46.5 pg/mL or sCD14≥2.0 μg/mL at enrolment demonstrated the same results. Kaplan‐Meier analysis also revealed IL‐8 and sCD14 to be significantly associated with a poor outcome. sCD14 was significantly correlated with IL‐8. EndoCAb and I‐FABP were not related to disease outcome.\u003cbr/\u003eConclusions\u003cbr/\u003eSerum IL‐8 and sCD14 levels before UDCA therapy represent noninvasive surrogate markers of prognosis in patients with PBC.", "subitem_description_type": "Abstract"}]}, "item_6_description_30": {"attribute_name": "資源タイプ(コンテンツの種類)", "attribute_value_mlt": [{"subitem_description": "Article", "subitem_description_type": "Other"}]}, "item_6_description_5": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "LIVER INTERNATIONAL.37(6):897-905(2016)", "subitem_description_type": "Other"}]}, "item_6_link_3": {"attribute_name": "信州大学研究者総覧へのリンク", "attribute_value_mlt": [{"subitem_link_text": "Umemura, Takeji", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.ymSpgpkh.html"}]}, "item_6_link_67": {"attribute_name": "WoS", "attribute_value_mlt": [{"subitem_link_text": "Web of Science", "subitem_link_url": "http://gateway.isiknowledge.com/gateway/Gateway.cgi?\u0026GWVersion=2\u0026SrcAuth=ShinshuUniv\u0026SrcApp=ShinshuUniv\u0026DestLinkType=FullRecord\u0026DestApp=WOS\u0026KeyUT=000403921100017"}]}, "item_6_publisher_4": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "WILEY"}]}, "item_6_relation_47": {"attribute_name": "PubMed", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "27860118"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://www.ncbi.nlm.nih.gov/pubmed/27860118", "subitem_relation_type_select": "PMID"}}]}, "item_6_relation_48": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "10.1111/liv.13316"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1111/liv.13316", "subitem_relation_type_select": "DOI"}}]}, "item_6_rights_62": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "This is the peer reviewed version of the following article: [Umemura, Takeji. et al. \"Association between serum soluble CD14 and IL‐8 levels and clinical outcome in primary biliary cholangitis\". LIVER INTERNATIONAL.37(6):897-905(2016)], which has been published in final form at [https://doi.org/10.1111/liv.13316]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions."}]}, "item_6_select_64": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "author"}]}, "item_6_source_id_35": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1478-3223", "subitem_source_identifier_type": "PISSN"}]}, "item_6_source_id_39": {"attribute_name": "NII ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1478-3223", "subitem_source_identifier_type": "PISSN"}]}, "item_6_source_id_40": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AA11817539", "subitem_source_identifier_type": "NCID"}]}, "item_6_text_69": {"attribute_name": "wosonly authkey", "attribute_value_mlt": [{"subitem_text_value": "decompensation; liver-related death; microbial translocation; primary biliary cholangitis; transplantation"}]}, "item_6_text_70": {"attribute_name": "wosonly keywords", "attribute_value_mlt": [{"subitem_text_value": "FATTY LIVER-DISEASE; CHRONIC HEPATITIS-C; BIOCHEMICAL RESPONSE; URSODEOXYCHOLIC ACID; PEGYLATED INTERFERON; GENE POLYMORPHISMS; RIBAVIRIN THERAPY; JAPANESE PATIENTS; EPITHELIAL-CELLS; GUT MICROBIOTA"}]}, "item_6_textarea_68": {"attribute_name": "wosonly abstract", "attribute_value_mlt": [{"subitem_textarea_value": "Background \u0026 Aims: Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by portal inflammation and immune-mediated destruction of intrahepatic bile ducts that often leads to liver decompensation and liver failure. Although the biochemical response to ursodeoxycholic acid (UDCA) can predict disease outcome in PBC, few biomarkers have been identified as prognostic tools applicable prior to UDCA treatment. We therefore sought to identify such indicators of long-term outcome in PBC in the Japanese population. \u003cbr/\u003eMethods: The prebiopsy serum samples and subsequent clinical data of 136 patients with PBC treated with UDCA were analysed over a median follow-up period of 8.8 years. Serum levels of biomarkers related to microbial translocation (sCD14, EndoCAb and I-FABP) were measured along with those of 33 cytokines and chemokines and additional auto-antibodies. Associations between the tested parameters and the clinical outcomes of liver decompensation and liver-related death/liver transplantation were evaluated using the Cox proportional hazards model with stepwise methods and Kaplan-Meier analysis. \u003cbr/\u003eResults: Elevated levels of serum IL-8, and sCD14 before UDCA therapy were significantly associated with both liver decompensation and liver-related death/liver transplantation. In multivariate analyses, IL-8 \u003e= 46.5 pg/mL or sCD14 \u003e= 2.0 mu g/mL at enrolment demonstrated the same results. Kaplan-Meier analysis also revealed IL-8 and sCD14 to be significantly associated with a poor outcome. sCD14 was significantly correlated with IL-8. EndoCAb and I-FABP were not related to disease outcome. \u003cbr/\u003eConclusions: Serum IL-8 and sCD14 levels before UDCA therapy represent noninvasive surrogate markers of prognosis in patients with PBC."}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Umemura, Takeji", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106729", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sekiguchi, Tomohiro", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106730", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Joshita, Satoru", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106731", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamazaki, Tomoo", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106732", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shibata, Soichiro", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106733", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ichikawa, Yuki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106734", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Komatsu, Michiharu", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106735", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Matsumoto, Akihiro", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106736", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shums, Zakera", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106737", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Norman, Gary L.", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106738", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tanaka, Eiji", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106739", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ota, Masao", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106740", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2018-10-31"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "LIVint-16-00824R1.pdf", "filesize": [{"value": "238.3 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensefree": "This is the peer reviewed version of the following article: [Umemura, Takeji. et al. \"Association between serum soluble CD14 and IL‐8 levels and clinical outcome in primary biliary cholangitis\". LIVER INTERNATIONAL.37(6):897-905(2016)], which has been published in final form at [https://doi.org/10.1111/liv.13316]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.", "licensetype": "license_note", "mimetype": "application/pdf", "size": 238300.0, "url": {"label": "LIVint-16-00824R1.pdf", "url": "https://soar-ir.repo.nii.ac.jp/record/20235/files/LIVint-16-00824R1.pdf"}, "version_id": "d788fc7a-ad91-4962-9996-5cd6bc19bc14"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "decompensation", "subitem_subject_scheme": "Other"}, {"subitem_subject": "liver‐related death", "subitem_subject_scheme": "Other"}, {"subitem_subject": "microbial translocation", "subitem_subject_scheme": "Other"}, {"subitem_subject": "primary biliary cholangitis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "transplantation", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis", "subitem_title_language": "en"}]}, "item_type_id": "6", "owner": "1", "path": ["462"], "permalink_uri": "http://hdl.handle.net/10091/00020993", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2018-10-31"}, "publish_date": "2018-10-31", "publish_status": "0", "recid": "20235", "relation": {}, "relation_version_is_last": true, "title": ["Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis"], "weko_shared_id": -1}
  1. 050 医学部, 大学院医学系研究科
  2. 0501 学術論文

Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis

http://hdl.handle.net/10091/00020993
http://hdl.handle.net/10091/00020993
a8a9aae3-4baa-4632-b12f-a144bc3c60e9
名前 / ファイル ライセンス アクション
LIVint-16-00824R1.pdf LIVint-16-00824R1.pdf (238.3 kB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2018-10-31
タイトル
言語 en
タイトル Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis
言語
言語 eng
キーワード
主題Scheme Other
主題 decompensation
キーワード
主題Scheme Other
主題 liver‐related death
キーワード
主題Scheme Other
主題 microbial translocation
キーワード
主題Scheme Other
主題 primary biliary cholangitis
キーワード
主題Scheme Other
主題 transplantation
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ journal article
著者 Umemura, Takeji

× Umemura, Takeji

WEKO 106729

en Umemura, Takeji

Search repository
Sekiguchi, Tomohiro

× Sekiguchi, Tomohiro

WEKO 106730

en Sekiguchi, Tomohiro

Search repository
Joshita, Satoru

× Joshita, Satoru

WEKO 106731

en Joshita, Satoru

Search repository
Yamazaki, Tomoo

× Yamazaki, Tomoo

WEKO 106732

en Yamazaki, Tomoo

Search repository
Shibata, Soichiro

× Shibata, Soichiro

WEKO 106733

en Shibata, Soichiro

Search repository
Ichikawa, Yuki

× Ichikawa, Yuki

WEKO 106734

en Ichikawa, Yuki

Search repository
Komatsu, Michiharu

× Komatsu, Michiharu

WEKO 106735

en Komatsu, Michiharu

Search repository
Matsumoto, Akihiro

× Matsumoto, Akihiro

WEKO 106736

en Matsumoto, Akihiro

Search repository
Shums, Zakera

× Shums, Zakera

WEKO 106737

en Shums, Zakera

Search repository
Norman, Gary L.

× Norman, Gary L.

WEKO 106738

en Norman, Gary L.

Search repository
Tanaka, Eiji

× Tanaka, Eiji

WEKO 106739

en Tanaka, Eiji

Search repository
Ota, Masao

× Ota, Masao

WEKO 106740

en Ota, Masao

Search repository
信州大学研究者総覧へのリンク
氏名 Umemura, Takeji
URL http://soar-rd.shinshu-u.ac.jp/profile/ja.ymSpgpkh.html
出版者
出版者 WILEY
引用
内容記述タイプ Other
内容記述 LIVER INTERNATIONAL.37(6):897-905(2016)
書誌情報 LIVER INTERNATIONAL

巻 37, 号 6, p. 897-905, 発行日 2016-11-17
抄録
内容記述タイプ Abstract
内容記述 Background & Aims<br/>Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by portal inflammation and immune‐mediated destruction of intrahepatic bile ducts that often leads to liver decompensation and liver failure. Although the biochemical response to ursodeoxycholic acid (UDCA) can predict disease outcome in PBC, few biomarkers have been identified as prognostic tools applicable prior to UDCA treatment. We therefore sought to identify such indicators of long‐term outcome in PBC in the Japanese population.<br/>Methods<br/>The prebiopsy serum samples and subsequent clinical data of 136 patients with PBC treated with UDCA were analysed over a median follow‐up period of 8.8 years. Serum levels of biomarkers related to microbial translocation (sCD14, EndoCAb and I‐FABP) were measured along with those of 33 cytokines and chemokines and additional auto‐antibodies. Associations between the tested parameters and the clinical outcomes of liver decompensation and liver‐related death/liver transplantation were evaluated using the Cox proportional hazards model with stepwise methods and Kaplan‐Meier analysis.<br/>Results<br/>Elevated levels of serum IL‐8, and sCD14 before UDCA therapy were significantly associated with both liver decompensation and liver‐related death/liver transplantation. In multivariate analyses, IL‐8≥46.5 pg/mL or sCD14≥2.0 μg/mL at enrolment demonstrated the same results. Kaplan‐Meier analysis also revealed IL‐8 and sCD14 to be significantly associated with a poor outcome. sCD14 was significantly correlated with IL‐8. EndoCAb and I‐FABP were not related to disease outcome.<br/>Conclusions<br/>Serum IL‐8 and sCD14 levels before UDCA therapy represent noninvasive surrogate markers of prognosis in patients with PBC.
資源タイプ(コンテンツの種類)
内容記述タイプ Other
内容記述 Article
ISSN
収録物識別子タイプ PISSN
収録物識別子 1478-3223
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AA11817539
PubMed
識別子タイプ PMID
関連識別子 https://www.ncbi.nlm.nih.gov/pubmed/27860118
関連名称 27860118
DOI
識別子タイプ DOI
関連識別子 https://doi.org/10.1111/liv.13316
関連名称 10.1111/liv.13316
権利
権利情報 This is the peer reviewed version of the following article: [Umemura, Takeji. et al. "Association between serum soluble CD14 and IL‐8 levels and clinical outcome in primary biliary cholangitis". LIVER INTERNATIONAL.37(6):897-905(2016)], which has been published in final form at [https://doi.org/10.1111/liv.13316]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
出版タイプ
出版タイプ AM
出版タイプResource http://purl.org/coar/version/c_ab4af688f83e57aa
WoS
表示名 Web of Science
URL http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=ShinshuUniv&SrcApp=ShinshuUniv&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000403921100017
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 08:08:45.644387
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3